[DOI] [PMC free article] [PubMed] [Google Scholar] 11.He L., Wei Q., Liu J., Yi M., Liu Y., Liu H., Sun L., Peng Y., Liu F., Venkatachalam M.A., et al
A diverse and balanced diet and a healthy lifestyle are important
However, compounded semaglutide is not FDA-approved for weight loss, and individual results may vary
The Promise of Future Treatment Researchers believe GLP-1 medications could become an important addition to addiction treatment for several reasons: Broader appeal : The popularity of Ozempic and similar drugs may reduce the stigma around taking medication for addiction Dual benefits : Many people with alcohol use disorder also struggle with weight issues, making these medications potentially helpful on multiple fronts Novel mechanism : GLP-1 drugs work differently than existing addiction medications, offering hope for those who haven't responded to current treatments Beyond Alcohol: Effects on Other Addictive Behaviors Interestingly, the effects of GLP-1 medications may extend beyond alcohol
The latter may be overcome by the use of universal donor iPSCs, produced by knocking out components of the human leukocyte antigen 36
Individual Genetic Factors Influencing Discontinuation Risk Genetic variants in GLP1R, GIPR, FTO, and MC4R genes influence how individuals respond to GLP-1 medications and how quickly they regain weight after stopping